Association of Serum Metabolomic Signatures with Survival in Pancreatic Cancer Patients Undergoing Neoadjuvant Therapy
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · e17-e18
DOI: 10.1016/j.ijrobp.2026.06.693 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von D. Choudhary und 4 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Choudhary, D., Pudakalakatti, S., Liu, S., Bhattacharya, P., & Koay, E. (2026). Association of Serum Metabolomic Signatures with Survival in Pancreatic Cancer Patients Undergoing Neoadjuvant Therapy. International Journal of Radiation Oncology*Biology*Physics, 126(1), e17-e18. https://doi.org/10.1016/j.ijrobp.2026.06.693
Vancouver
Choudhary D, Pudakalakatti S, Liu S, Bhattacharya P, Koay E. Association of Serum Metabolomic Signatures with Survival in Pancreatic Cancer Patients Undergoing Neoadjuvant Therapy. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):e17-e18. doi:10.1016/j.ijrobp.2026.06.693
BibTeX
@article{Choudhary2026,
author = {Choudhary, D. and Pudakalakatti, S. and Liu, S. and Bhattacharya, P. and Koay, E.J.},
title = {Association of Serum Metabolomic Signatures with Survival in Pancreatic Cancer Patients Undergoing Neoadjuvant Therapy},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {e17--e18},
doi = {10.1016/j.ijrobp.2026.06.693}
}
EUVIMED